These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22226771)

  • 21. [Biologics: current therapeutic strategies for rheumatoid arthritis].
    Tanaka Y
    Nihon Rinsho; 2007 Jul; 65(7):1179-84. PubMed ID: 17642229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [DDS preparations of drugs for inflammatory bowel disease].
    Takada K
    Nihon Rinsho; 1999 Nov; 57(11):2508-15. PubMed ID: 10572421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging therapeutic strategies for chronic inflammatory diseases.
    Ferrer E
    Drug News Perspect; 2006; 19(6):353-8. PubMed ID: 16971972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small molecules with anti-inflammatory properties in clinical development.
    Hanke T; Merk D; Steinhilber D; Geisslinger G; Schubert-Zsilavecz M
    Pharmacol Ther; 2016 Jan; 157():163-87. PubMed ID: 26627986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel transdermal targeting in steroid therapy: evaluation of PK/PD profiles using an animal model of rheumatoid arthritis.
    Komuro M; Kakuo H; Sawada K; Kawaguchi Y
    Pharmazie; 2002 Feb; 57(2):147. PubMed ID: 11878193
    [No Abstract]   [Full Text] [Related]  

  • 26. Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art.
    Rahman M; Kumar V; Beg S; Sharma G; Katare OP; Anwar F
    Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1597-608. PubMed ID: 26758815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa.
    Collnot EM; Ali H; Lehr CM
    J Control Release; 2012 Jul; 161(2):235-46. PubMed ID: 22306429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention of cardiovascular diseases in rheumatoid arthritis].
    Novikova DS; Popkova TV; Nasonov EL
    Ter Arkh; 2009; 81(5):88-96. PubMed ID: 19537595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanomedicines for inflammatory diseases.
    Khaja FA; Koo OM; Önyüksel H
    Methods Enzymol; 2012; 508():355-75. PubMed ID: 22449935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease.
    Guo Y; Zong S; Pu Y; Xu B; Zhang T; Wang B
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29973488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel drug delivery strategies for the treatment of inflammatory bowel disease.
    Kesisoglou F; Zimmermann EM
    Expert Opin Drug Deliv; 2005 May; 2(3):451-63. PubMed ID: 16296767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New oral delivery systems for treatment of inflammatory bowel disease.
    Friend DR
    Adv Drug Deliv Rev; 2005 Jan; 57(2):247-65. PubMed ID: 15555741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of rheumatoid arthritis in the 21st century: targeting B-lymphocytes.
    Brezinschek HP; Brickmann K; Yazdani-Biuki B; Dörner T; Graninger WB; Brezinschek RI
    Wien Med Wochenschr; 2006 Jan; 156(1-2):61-7. PubMed ID: 16465615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy in multiple sclerosis.
    Milo R; Panitch H
    J Neuroimmunol; 2011 Feb; 231(1-2):23-31. PubMed ID: 21111490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomal drug formulations in the treatment of rheumatoid arthritis.
    van den Hoven JM; Van Tomme SR; Metselaar JM; Nuijen B; Beijnen JH; Storm G
    Mol Pharm; 2011 Aug; 8(4):1002-15. PubMed ID: 21634436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug targeting strategies for the treatment of inflammatory bowel disease: a mechanistic update.
    Dahan A; Amidon GL; Zimmermann EM
    Expert Rev Clin Immunol; 2010 Jul; 6(4):543-50. PubMed ID: 20594127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Budesonide in the treatment of inflammatory bowel disease.
    Silverman J; Otley A
    Expert Rev Clin Immunol; 2011 Jul; 7(4):419-28. PubMed ID: 21790284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic targeting of molecules involved in leukocyte-endothelial cell interactions.
    Kaneider NC; Leger AJ; Kuliopulos A
    FEBS J; 2006 Oct; 273(19):4416-24. PubMed ID: 16956369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-articular drug delivery systems for the treatment of rheumatic diseases: a review of the factors influencing their performance.
    Butoescu N; Jordan O; Doelker E
    Eur J Pharm Biopharm; 2009 Oct; 73(2):205-18. PubMed ID: 19545624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour necrosis factor-alpha as a new therapeutic target for rheumatoid arthritis: an update.
    Giasuddin AS; Hoque ME; Ahmed ZU
    Bangladesh Med Res Counc Bull; 2005 Dec; 31(3):88-94. PubMed ID: 17549869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.